Literature DB >> 32038821

Metabolomics, a New Promising Technology for Toxicological Research.

Kyu-Bong Kim1, Byung Mu Lee2.   

Abstract

Metabolomics which deals with the biological metabolite profile produced in the body and its relation to disease state is a relatively recent research area for drug discovery and biological sciences including toxicology and pharmacology. Metabolomics, based on analytical method and multivariate analysis, has been considered a promising technology because of its advantage over other toxicogenomic and toxicoproteomic approaches. The application of metabolomics includes the development of biomarkers associated with the pathogenesis of various diseases, alternative toxicity tests, high-throughput screening (HTS), and risk assessment, allowing the simultaneous acquisition of multiple biochemical parameters in biological samples. The metabolic profile of urine, in particular, often shows changes in response to exposure to xenobiotics or disease-induced stress, because of the biological system's attempt to maintain homeostasis. In this review, we focus on the most recent advances and applications of metabolomics in toxicological research. © Korean Society of Toxicology 2008.

Entities:  

Keywords:  Biomarker; High-throughput screening (HTS); Metabolomics; Risk assessment; Toxicology

Year:  2009        PMID: 32038821      PMCID: PMC7006259          DOI: 10.5487/TR.2009.25.2.059

Source DB:  PubMed          Journal:  Toxicol Res        ISSN: 1976-8257


  75 in total

Review 1.  NMR-based metabolomics.

Authors:  Nicholas V Reo
Journal:  Drug Chem Toxicol       Date:  2002-11       Impact factor: 3.356

Review 2.  Metabolomics and biochemical profiling in drug discovery and development.

Authors:  Steven M Watkins; J Bruce German
Journal:  Curr Opin Mol Ther       Date:  2002-06

3.  Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles.

Authors:  Jun Yang; Guowang Xu; Qunfa Hong; Hartmut M Liebich; Katja Lutz; R-M Schmülling; Hans Günther Wahl
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-12-25       Impact factor: 3.205

Review 4.  FT-ICR mass spectrometry in the drug discovery process.

Authors:  Juan Zhang; Gregor McCombie; Christian Guenat; Richard Knochenmuss
Journal:  Drug Discov Today       Date:  2005-05-01       Impact factor: 7.851

5.  NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach.

Authors:  N J Waters; E Holmes; A Williams; C J Waterfield; R D Farrant; J K Nicholson
Journal:  Chem Res Toxicol       Date:  2001-10       Impact factor: 3.739

6.  Neural networks and physical systems with emergent collective computational abilities.

Authors:  J J Hopfield
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

7.  Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD.

Authors:  T F Bathen; T Engan; J Krane; D Axelson
Journal:  Anticancer Res       Date:  2000 Jul-Aug       Impact factor: 2.480

8.  Proton NMR spectra of urine as indicators of renal damage. Mercury-induced nephrotoxicity in rats.

Authors:  J K Nicholson; J A Timbrell; P J Sadler
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

9.  Studying rat brain neurochemistry using nanoprobe NMR spectroscopy: a metabonomics approach.

Authors:  Purnima Khandelwal; Chad E Beyer; Qian Lin; Lee E Schechter; Alvin C Bach
Journal:  Anal Chem       Date:  2004-07-15       Impact factor: 6.986

10.  Altered urinary profiles of polyamines and endogenous steroids in patients with benign cervical disease and cervical cancer.

Authors:  Seon Hwa Lee; Yoon Jung Yang; Kyung Mee Kim; Bong Chul Chung
Journal:  Cancer Lett       Date:  2003-11-25       Impact factor: 8.679

View more
  2 in total

Review 1.  Unravelling the Anticancer Mechanisms of Traditional Herbal Medicines with Metabolomics.

Authors:  Omolola R Oyenihi; Ayodeji B Oyenihi; Joseph O Erhabor; Motlalepula G Matsabisa; Oluwafemi O Oguntibeju
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

2.  A Metabolomics Approach to Sulforaphane Efficacy in Secondhand Smoking-Induced Pulmonary Damage in Mice.

Authors:  Hongyoon Kim; Sunju Yoo; Jung-Dae Lee; Hyang-Yeon Kim; Suhkmann Kim; Kyu-Bong Kim
Journal:  Metabolites       Date:  2022-06-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.